Rivastigmine in Multiple Sclerosis Patients With Cognitive Impairment

NCT00881205 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

86

Enrollment

INDUSTRY

Sponsor class

Stopped Termination of study due to low enrollment

Conditions

Multiple Sclerosis
Cognitive Impairment

Interventions

DRUG: Rivastigmine transdermal patch
DRUG: Placebo

Sponsor

Novartis Pharmaceuticals